Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization by unknown
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The induction of cytotoxic response against syngeneic or autologous murine or
human tumor cells by pool allosensitization in bulkMLC wasdemonstrated by Bach
et al . (1, 2). Subsequently, weshowed theexistence ofmurine cytotoxic cell precursors
that can be activated to reactwith syngeneic tumor cells by single-donor allosensiti-
zation in bulk MLC, applying the limiting dilution cultures (LDC) t technique (3,
4) . We also showed that a high frequency (1/20) of cytotoxic cells can be elicited
in the same manner even against syngeneic, weakly immunogeneic (MT2, mam-
mary carcinoma in C3H mice ; M109, lung carcinoma in BALB/c mice) or nonim-
munogenic (PIR-2, x-irradiation-induced lymphoma in 136 mice) tumors (5, 6) . We
postulated that shared or crossreactive antigenic determinants between the allogeneic
leukocytes and the syngeneic tumor cells lead to the elicitation of the antisyngeneic
tumor cytotoxic (ASTC) cells . Similar findings were reported by others (7-11) . Re-
cently, we have demonstrated (12) that theASTC precursors are phenotypically "clas-
sical" CTL precursors (i.e., Thy-1' ; Lyt-2+ ; L3T4- ; asialo GMl -) rather than clas-
sical NK-type lymphokine-activated killer (LAK) cells that might have arisen in the
presence of the high concentration of IL-2 (>250 U/ml) in the LDC.
In ourMLC-LDC system, in which the syngeneic target cells were the syngeneic
PIR-2 cells, no ASTC response could be demonstrated by directly testing lympho-
cytes sensitized in bulkMLC (5, 6) . Thehigh ASTC frequency, as well as the antial-
lotarget response, were demonstrated in LDC wells plated with a low number of
MLC-derived responding cells (<200/well). As the number of responding cells plated
per well increased beyond a critical number (usually 500/well), a gradual decrease
ofASTC response was observed. No anti-PIR-2 cytotoxicity could be detected when
>5,000 MLC-derived cellswere plated per well in LDC (3-5), whereas the percentage
of cytotoxically positive wells against the allotarget, as well as the level of antial-
locytotoxicity of the individual wells, remained at maximum .
This work was supported by grant 85-00107 from the United States-Israel Binational Science Founda-
tion, Jerusalem, Israel, and by grants from The Concern Foundation Inc., Los Angeles, CA, and the
Research Associates of the Lautenberg Center.
Address correspondence to Benny Leshem, The Lautenberg Center for General and TumorImmu-
nology, The Hebrew University-Hadassah Medical School, P O. Box 1172, Jerusalem 91010, Israel .
I Abbreviations used in thispaper . ASTC, antisyngeneic tumor cytotoxicity ; LAK, lymphokine-activated
killer; LDC, limiting dilution culture ; PLL, poly-L-lysine .
J . Exp. MED. © The Rockefeller University Press " 0022-1007/90/04/1057/15 $2 .00
￿
1057
Volume 171 April 1990 1057-10711058 SUPPRESSION OF ANTISYNGENEIC CYTOTOXIC T LYMPHOCYTES
Based on the above findings, we speculated (3-5) that suppressor cells, able to
block the cytotoxic response against the syngeneic tumor target, are activated in
bulk MLC. When the MLC-sensitized cells are then plated at low numbers in the
LDC wells, the suppressor cells are diluted out, thereby allowing the manifestation
of ASTC response, whereas LDC wells plated with high numbers (>500) of cells,
as in bulk MLC, contain suppressor cellsin sufficient numbers to cause the decrease
of ASTC response (3-5). The same interpretation of similar phenomena was sug-
gested by others (13-16).
In this study, we directly demonstrate the existence of radioresistant, Thy-1 + , Lyt-
2', L3T4- suppressor cells that specifically suppress, in a noncytolytic mechanism,
the cytotoxic response against syngeneic tumor target cells at the effector phase. Based
on data reported here and in other studies (3-5, 11), showing that the same B6 T
cell clone can lyse both the syngeneic tumor and the allogeneic target cells, we as-
sume that a single MLC-derived CTL may exhibit two killing activities: one directed
against the allotarget and the other against the syngeneic target cells. Only the an-
tisyngeneic response is suppressed by CD8' suppressor cells, in an as yet unknown
mechanism.
Materials and Methods
Mice.
￿
Female C57BL/6 (B6, H-2b), BALB/c (H-2d), C3H (H-2k), and strain A (H-2K';
Dd) mice, aged 6-12 wk, were used.
Medium.
￿
DME (Biological Industries, Beth Haemek, Israel) was supplemented with 10%
FCS, 1 mM sodium pyruvate, 10 mM Hepes buffer, 0.5 mM asparagine-HCI, 0.03 mM folic
acid, 0.5 MM L-aspartic acid, 5 x 10-5 M 2-ME, 2 mM glutamine, and antibiotics (com-
plete DME).
Tumor Lines.
￿
PIR2 thymoma was induced in a B6 mouse by fractionated x-irradiation
(4 x 170 cGy) (16). To avoid prolonged maintenance in vitro, frozen aliquots of PIR2 were
thawed for use every 8-12 wk. The PIR2 tumor was repeatedly shown to be nonimmuno-
genic and to lack membrane gp-70 expression (5, 17). As allotarget, we used P815, a mastocy-
toma of DBA/2 (H-2d) origin. The tumor cell lineswere carried in vitro in complete DME.
MixedLeukocyteCulture(MLC).
￿
Responding spleen cells and irradiated (30 Gy) stimulating
splenocytes (1.25 x 106/ml each) were cocultured in 20 ml of complete DME, in 25-cm2 flasks
(Nunc, Roskilde, Denmark) for 5 d at 37'C, in a 10% CO2 air incubator.
Limiting Dilution Culture (LDC).
￿
Freshly obtained splenocytes or lymphocytes harvested
from 5-d MLC were plated in LDC as previously described (5, 18). Briefly, graded numbers
(10-50,000) of responding cells were cultured for 8-9 d in round-bottomed 96-well plates
(Nunc) in 16-24 replicates, in the presence of 106/well of irradiated (30 Gy) allogeneic spleno-
cytes and human rIL-2 (250 U/ml, Cetus Corp., Emeryville, CA) in a final volume of 0.2
ml complete DME. In some experiments (secondary LDC), the responding cells were ob-
tained from selected LDC wells.
Estimate ofCytotoxic Cell Frequency.
￿
Lymphocytes harvested from individual LDC wells(50-p1
aliquots) were transferred to conical-bottomed 96-well plates (Nunc) and tested in a 4-h 5'Cr
release assay as described previously (5). Frequency (f) ofcytotoxic cell precursors and corre-
lation coefficient of regression analysis for Poisson's distribution (r2) were calculated as de-
scribed elsewhere (5, 18). In all the experiments described herein, r2 was X0.9.
Assessment of Cytotoxic Activity.
￿
Lymphocytes harvested from MLC or pooled from LDC
wells (effector cells) were tested for cytotoxicity in a 4-h "Cr release assay, in conical-
bottomed 96-well plates, at four E/T cell ratios as described previously (5). Lytic units (LU)
were calculated from the cytotoxicity measured at the four E/T cell ratios (19). 1 LU was
defined as the number of effector cells necessary to cause 30% target cell lysis.
Mixing Experiments.
￿
Effector cells were admixed with putative suppressor cells in either
one of the following protocols: (a) the putative suppressor cells (2 x 103 or 105) were addedLESHEM AND KEDAR
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to wellscontaining the 50-,ul aliquots transferred from the individual LDC wells; or (b) effector
cells were pooled from LDC wells, counted, and then admixed with putative suppressor cells
at a 1 :1 cell ratio; the cell mixtures were further diluted to the desired E/T ratios. In both
protocols, S'Cr-labeled target cells (2 x 103/well) were added to the cell mixtures, and "Cr
release was measured aftera 4-h incubation. In protocol a, the apparent CTL frequency was
determined, and in protocol b, LU/106 were calculated.
Preparation ofLymphoblasts.
￿
3 x 107 spleen cells were cultured at 37 °C for 2 d with either
3 pg/ml Con A (Bio-Makor, Rehovot, Israel), 10 Rg/ml PHA-P (Difco Laboratories Inc.,
Detroit, MI) or 50 Rg/ml LPS (Difco Laboratories Inc.) in 10 ml complete DME (25-cm'
flasks, Nunc).
Cell Depletion.
￿
Spleen cells (107/ml) were incubated for 45 min at 4°C with either of the
following antibodies: monoclonal antiThy 1.2, monoclonalanti-Lyt-2.2 (both from Cedarlane,
Hornby, Canada) (final dilution 1 :250), anti-asialo GMl antiserum (Wako Chemicals, Osaka,
Japan) (final dilution 1 :200), or monoclonal anti-L3T4 antibody (1 :50 dilution of an acites
fluid from sublethally irradiated BALB/c mice injected intraperitoneally with the GK1.5 hy-
bridoma cell line). Antibody-treated cells were then pelleted and resuspended to the original
volume with LowTox rabbit complement (C'; Cedarlane) (final dilution 1 :10). After a 45-
min incubation at 37 °C, cells were washed three times before further use. All dilutions were
made in RPMI 1640 medium containing Hepes buffer, antibiotics, and 0.390' BSA.
Adsorption to Monolayers.
￿
Cell monolayers were prepared as described earlier (20). Briefly,
tissue culture petri dishes (5 cm, Nunc) were incubated with 2 ml poly-7.-lysine (PLL; mol
wt >20,000; Sigma Chemical Co., St. Louis, MO) (0.1 mg/ml in PBS) for 30 min at 37°C.
Excess of the PLL was washed with PBS. LPS-induced lymphoblasts (3 x 107 viable
cells/dish) were incubated on the PLL-coated dishes for 30 min at 37 °C. The nonadherent
cells were aspirated and the monolayer was rinsed with HBSS-10% FCS. For adsorption,
cells harvested from 5-d bulk MLC (5-7 x 106 in 2 ml HBSS-10°70 FCS) were overlayed on
the lymphoblast monolayers. The petri dishes were then centrifuged for 2 min at 300 rpm
and incubated for 30 min at 37°C. The nonadherent cells were collected by gentle agitation.
Results
Lysis ofSyngeneicandAllogeneic Targets IsMediated by theSame CellClone.
￿
To reaffirm
our initial observation that the same cytotoxic cell clone that lysed the syngeneic
tumor PIR2 also killed the corresponding allotarget (3, 5), B6 a/BALB MLC-
sensitized lymphocytes were plated in LDC at 0.1 (Fig. 1 A) or at 0.2 (B) cells/well
(clone probability of 95 and 90%, respectively; plating efficiency of 50 and 33%,
respectively). Cytotoxic activity of the cloned cells harvested from the LDC wells
was tested against PIR2 and P815 target cells. As seen in Fig. 1, none of the clones
could lyse PIR-2 only, and 17-30% of them lysed the allogeneic target P815 only.
The majority (50-60%) were able to lyse both allogeneic and the syngeneic PIR2.
As was demonstrated previously (5, 12), both target cells were lysed by Thy-1 +, Lyt-
2+ , L3T4", asialo GMl - effector cells. The data suggest that the same CTL clones
that lyse the syngeneic target PIR2 also lyse the allogeneic target P815.
Suppression ofAS7C Response in LDC
￿
The observation indicating the existence
of anti-ASTC suppressor cells in the PIR-2 cells system is depicted in Fig. 2. Lym-
phocytes derived from bulk B6 aJBALB MLC were plated in LDC at 10-50,000
cells/well with 106 irradiated BALB/c splenocytes as stimulating cells and 250 U/ml
of IL-2 (B6 a/BALB LDC). Cytotoxic activity of cells harvested from individual
LDC wells against syngeneic (PIR-2) and allogeneic (P815) target cells was tested
8 d later. As seen in Fig. 2, when responding cells were plated at 10-200 cells/well
(low cell-number LDC), the percentage of wells cytotoxically positive against both
P815 and PIR2 increased concomitantly with the increase of the number of cells1060
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Lysisof syngeneic
tumorandallogeneic target cells
is mediated by the same CTL.
Lymphocytes derived from B6
a/BALB bulk MLCwere plated
in LDC wells, at 0.1 (A)and0.2
(B) cells/well, with 106 irradi-
ated BALB/c splenocytes and
50 U IL-2 per well, and were
cultured for 9 d. Cytotoxicity
against the allogeneic target
P815 and the syngeneictumor
PIR-2 was tested on cells har-
vested from individual wells.
originally plated in the wells. The frequencies of CTL (CTL-f) against P815 and
against PIR2, as determined from the LDC curves at this range, were 1/18 and 1/36,
respectively. In contrast, when the number of cells plated increased to >,500/well
(high cell-number LDC), the percentage of cytotoxically positive wells against the
syngeneic target PIR2 markedly decreased, yet the cytotoxicity of cells from the
same LDC wells against the allogeneic target P815 remained at maximal level even
when 50,000 cells were plated per well.
The described decrease in anti-PIR2 response might be due to selective death
of the double-reactive anti-PIR-2 anti-P815 CTL (50-60% of the cells; Fig. 1), but
not of the specific anti-P815 CTL (17-30%), in the high cell-number LDC wells.
To test ifthis was the case, B6 a/BALB LDC was set up, plating 50 and 50,000 MLC-
derived cells/well (500 wells each). Cells harvested from the individual wells were
tested for cytotoxicity against both PIR2 and P815 target cells. The remaining lym-
phocytes were then pooled in two separate groups as follows: cells from wells origi-
nally plated at 50 cells/well that were cytotoxically positive against both PIR2 and
P815 (PIR+ P815+; Table I, group a), and cells from wells originally plated at 50,000W
Q
W
Z
100
to
W
m
J
10
V
CELLS / CULTURE
20 50
￿
100 500 1p00
￿
2p00
￿
WW
￿
10,000 20,000
LESHEM AND KEDAR
￿
1061
IN n+
FIGURE 2.
￿
Elicitation and suppression of cytotoxicity against the syngeneic tumor PIR-2 in al-
logeneic LDC. 136 a/BALB MLC cells were plated in allogeneic LDC. Cytotoxicity (4-h 5 'Cr
release assay) was assayed afteran 8-d incubation against the allogeneic (P815; A) and syngeneic
(PIR2; ") target cells. (`) 0% negative wells (all wells are cytotoxic).
cells/well that were cytotoxically positive only against the allogeneic target (PIR-2 -
P815 +; Table I, group b). The pooled cells were then replated in LDC conditions
with IL-2 and BALB/c stimulating cells. Table I shows that although the cells of
group b appeared initially to be devoid of anti-PIR2 cytotoxic cell activity (PIR-
2-,P815+), the frequency ofanti-PIR2 CTL among these cells, as detected by the
secondary LDC, was high and similar to that found among the PIR-2+,P815 +
cells of group a. Thus, the data indicate that the lack ofanti-PIR-2 activity in the
high cell number PIR- P815' LDC wells was not due to selective death ofanti-PIR-
2 CTL.
We hypothesized that suppressor cells, able to block the response only against the
syngeneic target cells PIR-2, are induced during allosensitization in bulk MLC. In
TABLE I
Existence of Anti-PIR-2 CTL in High Cell-number PIR-2" LDC Wells
Cells harvested from allogeneic LDC wells originally plated at 50 cells/well that
were cytotoxic against both P815 and PIR-2 (PIR-2' P815*) (group a), and
at 50,000 cells/well that were cytotoxic against P815 only (PIR-2- P815+ ), were
replated in allogeneic LDC conditions. 4-h 5 'Cr release was measured after in-
cubation of 9 d. CTL frequency was calculated as described in Materials and
Methods.
50,000
No. of cells Cytotoxic
plated per well activity in Anti-PIR-2
Group in primary LDC primary LDC frequency
a 50 PIR-2' P815` 1/32
b 50,000 PIR-2- P815' 1/151062
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the low cell-number LDC wells, the suppressor cells are diluted out, allowing the
manifestation ofthe anti-PIR2 cytotoxicity. When>500 MLC-derivedlymphocytes
are plated per well (high cell-number LDC), enough suppressor cells are present
in the wells to block the cytotoxic response against PIR2. Our finding that high
cell-number LDC wells contain high frequency ofanti-PIR2 CTL (Table I) also
suggests that the described suppression takes place at the effector phase and not at
the induction of anti-PIR-2 CTL.
Suppression ofAS7L Response in Mixing Experiments.
￿
Thenotion ofsuppressor cells
inhibiting the ASTC response was substantiated in mixing experiments. In a pre-
liminary experiment (data not shown), we found that cells harvested from high
cell-number (50,000 cells/well), PIR2 -,P815` LDC wells were suppressive. This
conclusion was based on the findingthat mixing these cells (1:1 ratio) with lympho-
cytes harvested from low cell-number (50 cells/well), PIR2+ P815' LDC wells
resulted in a 75% decrease in anti-PIR2 cytotoxicity, whilefreshlyobtained B6 spleen
cells were not significantly suppressive.
Since bulk MLC-derivedlymphocytes do notexhibit any anti-PIR2 cytotoxicity,
in spite ofthe high anti-PIR2 CTL-f among them (as evidenced by LDC analysis
of low cell-number wells), we assumed that these cells could be used as a source
of suppressor cells. Suppression of ASTC response by MLC-derived lymphocytes,
in two mixing experiments, isdescribed inTableII. Lymphocytesfrom various sources
were added (10 5 cells/well) to 50 j.l aliquots from B6 a/BALB LDC wells (protocol
a ofthe mixing experiments in Materials and Methods). Only cells harvested from
TABLE II
Specificity of Suppression of ASTC Response by B6 alBALB
MLC-derived Lymphocytes
B6 lymphocytes (105/well) or supernatant (0.1 ml) were added to 50-dal ali-
quots from B6 a/BALB LDC wells. 30 min later, 5'Cr-labeled PIR-2 target
cells were added to the wells. 5'Cr release was measured after a 4-h incuba-
tion, and CTL frequency was calculated as described in Materials and Methods.
' B6 splenocytes were incubated for 3 d with 1,000 U/ml IL-2 .
Exp.
Cells added to
LDC plates
Anti-PIR-2
CTL frequency
1 None 1/72
B6 (fresh) 1/210
B6 (incubated) 1/80
B6 a/B6 MLC 1/91
B6 a/BALB MLC 1/890
B6 a/C3H MLC 1/190
B6 LAK cells' 1/130
Supernatant from B6
a/BALB MLC 1/77
2 None 1/35
B6 (fresh) 1/29
B6 a/BALB MLC 1/2230
B6 Con A blasts 1/52
B6 PHA blasts 1/35
B6 LPS blasts 1/29LESHEM AND KEDAR
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a B6 a/BALB MLC were able to significantly suppress anti-PIR2 cytotoxicity. In
contrast, freshly obtained B6 splenocytes, cultured unsensitized B6 cells, lympho-
cytes from B6 a/B6 MLC, B6 a/C3H MLC, and B6 LAK cells (induced by 1,000
U/ml IL-2), mitogen (Con A, PHA, and LPS)-stimulated B6 splenocytes, and a su-
pernatant (50% vol/vol) from B6 a/BALB MLC, did not significantly suppress anti-
PIR-2 cytotoxicity.
Phenotype ofthe Suppressor Cells.
￿
To phenotype the suppressor cells, lymphocytes
from B6 a/BALB MLC were pretreated with either antiThy-1.2, anti-Lyt-2.2, or
anti-L3T4 mAbs and C'. The mAB + C'-treated cells (and cells treated with C'
alone, as control), were then added to aliquots from LDC wells as detailed in the
previous experiment. Pretreatment with either antiThy-1.2 or anti-Lyt-2.2 + C',
but not with anti-L3T4 + C', abrogated the anti-ASTC suppressive capacity of B6
a/BALB MLC cells (Table III). Thus, the anti-ASTC suppressor cells are of the
CD8 type.
Specificity ofSuppression.
￿
To determine whether or not the suppressor cells block
only the response against the syngeneic PIR-2 target cells, LDC was set up in subop-
timal conditions (i.e., 50 U/ml of IL-2 instead of the standard 250 U/ml, see refer-
ence 12). We used here the suboptimal conditions, because in theseconditions, even
low numbers (2 x 103/well) of B6 a/BALB MLC-derived suppressor cells could sup-
press the anti PIR2 cytotoxicity without significant anti-P815 cytotoxicity (<5%).
The use of larger numbers of cells (105/well), necessary to suppress the anti-PIR2
cytotoxicity elicited in LDC in optimal conditions, caused by themselves 100% of
P815 lysis. Cells from bulk MLC (2 x 103/well) were added to 50-p,l aliquots from
the suboptimal LDC wells, as in the previous two experiments. Table IV shows a
10-fold decrease ofthe anti-PIR2 frequency caused by the addition of as few as 2 x
103 B6 a/BALB MLC-derived cells, while they did not affect the anti-P815 CTL
frequency. Under these experimental conditions, no significant lysis of P815 target
cells, directly caused by 2 x 103 B6 a/BALB MLC cells, was observed (data not
shown).
To further characterize the suppressor cells, anti-PIR2 effector cells were pooled
from wells oflow cell-number B6 a/BALB LDC (anti-PIR2 CTL frequency, 1/27;
TABLE III
Phenotype of the Anti-ASTC Suppressor Cells
B6 a/BALB MLC cells, pretreated as indicated, were added (105/well) to 50-Al
aliquots from individual B6 a/BALB LDC wells. 30 min later, 51Cr-labeled
PIR-2 target cells were added to the wells. 5'Cr release was measured after a
4-h incubation, and CTL frequency was calculated as described in Materials
and Methods.
Cells added
to LDC wells
Pretreatment
of added cells
Anti-PIR-2
frequency
None - 1/72
B6 a/BALB MLC - 1/860
B6 a/BALB MLC C' 1/890
B6 a/BALB MLC Anti-Thy-1 .2 + C' 1/150
B6 a/BALB MLC Anti-Lyt-2 .2 + C' 1/180
B6 a/BALB MLC Anti-L3T4 + C' 1/9501064 SUPPRESSION OF ANTISYNGENEIC CYTOTOXIC T LYMPHOCYTES
TABLE IV
Suppression of ASTC and not of Antiallogeneic Cytotoxic
Response Elicited in LDC
B6 lymphocytes (2 x 103/well) or supernatant (0.1 ml) were added to 50-JAI ali-
quots from B6 a/BALB LDC wells (set in suboptimal conditions, i.e., with 50 U
of IL-2/ml). 30 min later,5'Cr-labeled PIR-2 target cells were added to the wells.
5'Cr release was measured after a 4-h incubation, and CTL frequency was cal-
culated as described in Materials and Methods.
100 cells/well)and oflow cell-numberB6 a/C3H LDC (anti-PIR-2 CTL frequency,
1/360; 500 cells/well). The pooled anti-PIR2effector cells were mixedwithcells (1:1
ratio), supernatants, or IL-2, as detailedin TableV. Cytotoxicity againstPIR2 was
then tested at four E/T cell ratios, and LU/106 cells (defined at 30% lysis) for each
mixture were calculated. Results similar to those depicted in Table V were found
in twoto fiverepeated experiments. Asseen inTable V cells derived from B6 a/BALB
MLC (group 4) and from high cell-number (50,000 cells/well) PIR-2-P815+ B6
a/BALB LDC wells (group 12), but not from B6 a/C3H MLC (group 5), blocked
the anti-PIR2 cytotoxicityofCTLderived from B6a/BALB LDC (group 1); recipro-
cally, anti-PIR-2 cytotoxicity ofCTL derived from B6 a/C3H LDC (group 1) was
suppressed bycellsderived from B6a/C3H MLC (group 5), but not from B6 a/BALB
MLC (group 4). Moreover, the suppressive activity ofthe MLC-derived suppressor
cellscould be adsorbed onlyonlymphoblast monolayers ofthe samehaplotype that
had been used as stimulating cells in the bulk MLC. The suppressive capacity of
lymphocytes derivedfrom B6a/BALB MLC wasadsorbed onBALB/cbutnot C3H
monolayers (groups 6 and 7), and that of B6 a/C3H MLC was adsorbed only on
C3H monolayers (groups 8 and 9).
As in Table III, here too the MLC-derived suppressor cell activity was abrogated
by pretreatment with antiThy-1.2 or anti-Lyt-2.2 (groups 14 and 15, respectively),
but not with anti-L3T4 mAb + C' (group 16). Their activity was not affected by
30 Gyx-irradiation(group 10). Removal ofNK-LAK cell precursors (by anti-asialo
GM1 antibody + C') from B6 splenocytes, before allosensitization, did not affect
the suppressive capacity ofthe MLC-derivedlymphocytes(group 11), indicatingthat
the suppressor cells are not of NK-LAK cell lineage (21). IL-2 (250 U/ml, group
18) and B6a/BALB MLC supernatant (group 17) didnotchange theASTC activity.
The suppression ofanti-PIR-2 activity is not mediated by lysis ofthe anti-PIR-2
cytotoxic cells, since B6 a/BALB MLC lymphocytes did not lyse "Cr-labeled anti-
PIR2 cytotoxic cells (pooled from lowcell-numberLDC wells). Similarly, the MLC-
derived lymphocytes were not lysed by the anti-PIR2, LDC-derived effector cells
(data not shown).
Cells added
to LDC plates
Anti-PIR-2
CTL frequency
Anti-P815
CTL frequency
None 1/350 1/25
B6 (fresh) 1/270 1/30
B6 (incubated) 1/700 1/35
B6 a/BALB MLC 1/3420 1/30
B6 a/C3H MLC 1/900 1/20
Supernatant from B6
a/BALB MLC 1/290 1/35LESHEM AND KEDAR
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TABLE V
Phenotype and Specificity of Supprecsor Cells as Determined by Mixing Experiments
Anti-PIR-2 cytotoxicity
of cells derived from:
Cells were harvested from anti-PIR-2' wells of B6 a/BALB or 136 a/C3H LDC (plated origi-
nally with 100 and 500 cells/well, respectively) . The cells were mixed at a 1 :1 ratio with cells
from various sources, with or without pretreatment, as described in the table. The mixtures
were then diluted (four threefold dilutions) and 2 x 10; S]Cr-labeled PIR-2 cells were added
per well. S 'Cr release was measured after a 4-h incubation. LU were calculated at 30% lysis.
MLC-derived lymphocytes were first incubated on monolayers of either BALB/c- or C3H
LPS-induced lymphoblasts, and the nonadhering cells were admixed with anti-PIR-2 effec-
tor cells.
B6 splenocytes were treated to remove NK-LAK precursors before MLC.
Lymphocytes were harvested from LDC wells originally plated at 50,000 cells/well and were
not cytotoxic against PIR-2 .
Discussion
The paradox that in spite of the relatively high frequency of CTL with ASTC
activity detected by LDC among splenocytes freshly obtained from normal or tumor-
bearingmice or amonglymphocytes derived from allogeneic bulk MLC, noASTC
activity was mediated bythese cell populations (3-6, 11), led us to hypothesize (3-5)
that ASTC activity might beblocked by suppressor cells that coexist with theASTC
CTL.
The data presented in Fig. 2 support this hypothesis: when small numbers of re-
sponding cells were plated in LDC wells (low cell-number LDC), the putative sup-
pressor cells were presumably diluted out and full manifestation ofASTC response
could be observed. The number ofputative suppressor cells present in wells plated
with high numbers of responding cells (high cell-number LDC) sufficed to block
the ASTC response. The fact that decreasing the number ofcells plated per well
Group Cells added
Pretreatment of
added cells
B6
a/BALB LDC
B6
a/C3H LDC
LU1106
1 None 85 93
2 Fresh B6 118 95
3 MLC, B6 a/136 88 118
4 MLC, B6 a/BALB 31 112
5 MLC, 136 a/C3H 109 7
6 MLC, B6 a/BALB Adsorption on BALB` 79 ND
7 MLC, B6 a/BALB Adsorption on C3H` 21 ND
8 MLC, B6 a/C3H Adsorption on BALB" ND 10
9 MLC, B6 a/C3H Adsorption on C3H` ND 71
10 MLC, 136 a/BALB Irradiation (30Gy) 33 ND
11 MLC, B6 a/BALB Anti-ASGM1 + C'I 27 ND
12 LDC, B6 a/BALB
50,000 cells/well9 22 ND
13 MLC, B6 a/BALB C' 37 ND
14 MLC, B6 a/BALB Anti-Thy-1 .2 + C' 91 ND
15 MLC, 136 a/BALB Anti-Lyt-2.2 + C' 109 ND
16 MLC, 136 a/BALB Anti-L3T4 + C' 35 ND
17 Supernatant of B6
a/BALB (0.1 ml) 101 ND
18 IL-2 (250 U/ml) 91 ND1066
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caused the dilution out ofthe suppressor cells before that ofthe anti PIR2 cytotoxic
cells suggests that the frequency ofthe former cells is lower than that ofthe latter.
Since no decrease in the anti-P815 cytotoxicity wasobserved in high cell-number
LDC wells (Fig. 2), we ruled out the possibility that the decrease in ASTC activity
observed in these wells was the result of overall cell death (due to overcrowding).
We also ruled out the possibility that selective death ofASTC CTL or ASTC cell
"suicide" (lysis ofB6 antisyngeneic CTL by their identical counterparts) in high cell
densityconditions account forthe decrease inASTC activity. Suchmechanisms should
have resulted in a decrease in the relative number (or frequency) of ASTC CTL
in high cell-number LDC wells. However, as seen in Table I, the ASTC frequency
amongcellsharvested from highcell-number LDC wells, apparently devoid ofanti-
PIR2 cytotoxicity (PIR-2 -), was in fact similarto that found among cells harvested
from low cell-number, PIR-2+ LDC wells.
An alternative explanation for the decrease in the anti-PIR-2 response in wells
plated with high cell numbers is that the anti-PIR2 cytotoxic cells are more sensi-
tive to IL-2 concentration in the LDC wells than the specific antiallogeneic CTL.
However, we have previously shown (12) that the anti-PIR-2 effector cells are not
ofthe NK/LAK lineage, but rather "classical" CTL. Moreover, even a fivefold in-
crease in theIL-2 concentration in the LDC did not change the anti-PIR2 response.
Thesefindingsandthe fact thattheanti-PIR2 LDC curves fit to the single-hitPoisson's
distribution indicate that IL-2 concentration is not the limiting factor that could
cause the decrease in the anti-PIR2 reactivity in the high cell-number wells.
The fact that a high ASTC CTL frequency was found even among lymphocytes
harvested from PIR2- high cell-number LDC wells (Table 1) also indicates that
the suggested suppression is not operative at the level of induction ofASTC cells
but rather on their cytotoxic activity atthe effector phase; suppression ofthe induc-
tion of ASTC would have resulted in a reduced frequency of ASTC CTL among
cells harvested from PIR-2- high cell-number LDC wells. The existence of sup-
pressor cells regulating autologous cytotoxicity at the effector phase has been re-
cently reported incancer patients(22). In addition, Joly et al. (16) recently reported
the existence of CD8+ class I-nonrestricted suppressor cells that suppress, at the
effector phase, the cytotoxicity against autologous anti-HIV-infected target cells, as
well as the activity of antiautologous HLA CTL.
In mixing experiments, we demonstrated that, indeed, cells harvested from high
cell-numberB6 a/BALB LDC wells (Table V), and from B6a/BALB MLC-derived
lymphocytes (Tables IIV), both suppressed the ASTC activity of cells harvested
from lowcell-numberB6a/BALB LDC. The factthat supernatantfromB6a/BALB
MLC did not suppress this activity (Tables II, IV, andV)suggests thatthesuppres-
sion is mediated by cells rather thanby soluble factor(s). The anti-ASTC suppressor
cells, as the ASTC cells themselves (5), were phenotyped as CD8+ cells, i.e. Thy-
1+, Lyt-2+, L3T4-, and asialo GMl` cells (Tables III and V), and are radioresis-
tant. IL-2-elicited LAK cells were not suppressive (Table II).
The need for specifically allosensitized MLC-derived cells in the suppression of
ASTC response is demonstrated in Tables II, IV, and V. B6 splenocytes that were
allosensitized againstBALB/c(but not against C3H)splenocytes suppressed the ASTC
responseelicited in B6 a/BALB LDC. Inaddition, the suppressive activity ofMLC-
derived cells could be specifically adsorbed only on monolayers oflymphoblasts de-LESHEM AND KEDAR
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rived from the same haplotype used to stimulate the responding cells (Table V).
In preliminary experiments (data not shown), we also found that lymphocytes de-
rived from bulk MLC of B6 anti-strain A (H-2KkDd) suppressed the anti-PIR2
CTL activity induced in B6aBALB LDC as efficientlyaslymphocytes derived from
bulk MLC ofB6 anti-BALB/c (H-2KdDd). Moreover, B6 a/BALB MLC-induced
suppressor cells could be adsorbed on monolayers of BALB/c and ofstrain A, but
not on B6 orC3H (H-2k) lymphoblasts. Interestingly, BALB/c and strain Aspleno-
cytes were 10-fold more effective in eliciting anti-PIR-2 CTL than splenocytes from
C3H mice (datanot shown). Although additional experiments are needed to inves-
tigate the H-2 restriction pattern oftheelicitation ofASTC cells and theirsuppressors,
we have preliminary indications linking the H-2D region to the induction ofthese
activities in our experimental system.
The specificity of the suppressor cells was further demonstrated by the ability of
MLC-derived lymphocytes to suppress the anti-PIR-2, but not the anti-P815 cyto-
toxicity (Table IV). Suppression ofanti-PIR2 and not anti-P815 cytotoxicity is also
evident in high cell-number LDC (Fig. 2). Theexact mechanism ofthe suppression
of ASTC response is yet to be determined. However, we were able to demonstrate
that although the suppression is mediated by CTL-like CD8' cells, is does not ap-
pear to be caused by the lysis ofthe anti-PIR-2 effector cells themselves. The effec-
tive ratioofsuppressor/effector cellratios that resultedin CTL suppressionwas hard
to estimate. Although in the mixing experiments a 1 :1 ratio was used, it should be
noted that both "suppressor" cells (from bulk MLC) and "effector" cells (from PIR-
2+ LDC wells) were mixed populations in which we could not estimate the fre-
quency of the suppressor cells.
Theobservation that thesameCTLclone couldlyseboth syngeneic and allogeneic
target cells (5, 6, 11, and Fig. 1), and our data (23), showing that the antiallogeneic
cytotoxicity elicited in LDC could be blockedby mAbsdirected against H-2K prod-
ucts(MHC-restricted killing) whereasASTC response could not, led ustoconclude
that the Thy-1+, Lyt-2+, L3T4- cells induced by allosensitization exhibit at least
two distinct cytotoxic activities: one is the classical, MHC-restricted CTL activity
aimed specifically against the allogeneic H-2 determinants, and the other is aimed
against the syngeneic tumor PIR-2 and most likely against other syngeneic target
cells. Only the latter activity can be blocked by suppressor cells elicited by allosen-
sitization. The above preliminary observation also suggests that: (a) the target an-
tigens on PIR2 recognized by the ASTC cells are probably not crossreactive with
the H-2 K/Dd determinants on the BALB/c stimulating cells; and (b) the PIR2+,
P815+ CTL recognize their target cells via two distinct receptors present on the
same CTL.
That two different activities could be exhibited by the same T cell clone was al-
ready shown byothers: helper (IL-2 production)and cytotoxic activities (24); helper
and suppressive activities(25), andcytotoxic activity againsttwo distinct target cells
(26-28). In addition, MHC nonrestricted killing mediated by "classical" CTL and
loss of antigenic specificity were demonstrated in cases where classical, allogenei-
cally elicited CTL were carried in vitro with a high concentration ofIL-2 only, in
the absence ofthe alloantigen (29, 30). Cytotoxic activity against syngeneic target
cells exhibited by allogeneic CTL was also reported (31).
Since we(3-6) and others (7-11, 15, 28, 32, 33) were able to demonstrate the exis-1068 SUPPRESSION OF ANTISYNGENEIC CYTOTOXIC T LYMPHOCYTES
tence ofautoreactive (or ASTC) clones among normal murine and human lympho-
cytes, one might speculate that the function of the suppression described here is to
prevent autoimmune responses that might be elicited as a consequence ofnormal
or abnormal activity of the immune system. Our findings are in accordance with
the veto cell hypothesis, as described by Miller (34, 35) and by others (36-38): the
veto cells, with thephenotype andspecificity ofCTL, block, by anoncytolyticmech-
anism, the cytotoxic activity aimed atsyngeneic target cells. Additional preliminary
data(Leshem and Bach, unpublished results) showed that evencloned ASTC popu-
lations, when replated in allogeneic LDC, exhibited a decrease in ASTC response
in the high cell-number LDC wells, the same that characterizes the suppression
of ASTC response in allogeneic LDC using uncloned populations, as shown here
(Fig. 2). Based on this observation and assuming that the cloned ASTC population
had not undergone any change during their growth, we are tempted to speculate
that the ASTC cells themselves might be the suppressive cells.
We showed that allosensitization elicits cytotoxic response against syngeneic normal
lymphoblasts as well as ASTC response (3, 4), and that syngeneic (H-2b) cells block
the cytotoxicity against PIR2 (Leshem et al., unpublished results). We therefore
believe that the ASTC response induced by allostimulation, as described here, is
representative ofresponses against normal self antigens. ASTC cells (6) as well as
autoreactive cells (15, 32) were shown to exist among splenocytes of normal mice,
buttheiractivity maynormally notbemanifested becauseitis specificallysuppressed.
It may be that under certain conditions, as in low cell-number LDC where sup-
pressorcells are diluted out, or in autoimmune diseasesthat are often accompanied
byadecreasein suppressor cellactivity (39-42), theanti-selfresponse ismanifested.
Indeed, suppression of L3T4+ autoreactive cells by Lyt-2+ suppressor cells was re-
cently demonstrated, both in vitro and in vivo (43). In addition, CD8+ suppressor
cells thatblock, atthe effector phase, thecytotoxicity againstautologous HIVinfected
cells, as well as the activity ofantiautologous HLA CTL, were also identified (16).
Experiments in our laboratory are undertaken to elucidate the mechanism and
the MHC restriction patterns of the elicitation ofASTC response and its suppres-
sion and the relevance of these phenomena in vivo.
Summary
Sensitization ofC57BL/6 (B6, H-2b) splenocytes against normal BALB/c (H-2d)
leukocytes (B6 a/BALB) in bulk MLC induced CTL reactive against the syngeneic
(H-2b) nonimmunogenic lymphoma PIR2, in addition to the CTLdirected against
the corresponding (H-2d) allotargets. However, MLC-derived lymphocytes did not
directly exhibit anti-PIR2 cytotoxicity inspiteofthe high anti-PIR2 CTLfrequency
(up to 1/20) among them, as demonstrated by the limiting dilution culture (LDC)
technique. The presentstudy wasundertakento resolvethis contradiction. Wefound
that anti-PIR2 cytotoxicity could be detected only whenB6 a/BALB MLC-derived
responding cells were plated in LDC at low numbers (<200) of cells/well. In con-
trast, increasing the number of the plated cells to 500-5,000 resulted in a gradual
decrease inthe percentage ofwells cytotoxically reactiveagainst PIR-2, whereas the
percentage ofwells exhibiting cytotoxicity against theallotargets remained unchanged
(100%). This decrease ofanti-PIR2 cytotoxicity in LDC and the lack ofanti-PIR-2LESHEM AND KEDAR
￿
1069
reactivity among MLC-derived lymphocytes were shown by mixing experiments
to result from the activity of radioresistant Thy-1+ , Lyt-2', L3T4 - suppressor cells,
blocking the anti-PIR2 cytotoxicity at the effector phase. The suppression was specific
as indicated by the following observations: (a) freshly obtained B6 splenocytes, cul-
tured unsensitized B6 splenocytes, mitogen-induced B6 lymphoblasts, B6 LAK cells,
or 136 a/B6 MLC-derived lymphocytes were not suppressive; (b) anti-PIR2 cytotox-
icity elicited in B6 a/BALB LDC was suppressed only by lymphocytes derived from
B6 a/BALB MLC and not from B6 a/C3H (H-2k) MLC; and (c) B6 a/BALB MLC-
induced suppressor cells could be adsorbed on monolayers of BALB/c but not of
C3H lymphoblasts. Since both syngeneic tumor and allogeneic target cells were lysed
by the same clonal cell population but only the antisyngeneic activity was suppressed,
we suggest that a single CTL can exhibit two cytotoxic activities that are differen-
tially affected by the described suppressor cells. This mode of suppression may play
a role in controlling autoimmune reactivity.
We thank Cetus Corp., Emeryville, CA, for the generous supply of human rIL-2. We also
thank Dr. F. H . Bach for his critical review of this manuscript.
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